Clinical factors associated with shorter durable response, and patterns of acquired resistance to first-line pembrolizumab monotherapy in PD-L1-positive non-smallcell lung cancer patients: A retrospective multicenter study

Định dạng: PDF / Số trang: 11

Nhắn tin với admin nếu không tải được